To investigate whether our in vitro results could be extrapolated to the in vivo situation, we compared serum induced IR-A and IR-B activation (by using an IR-A and IR-B specific KIRA assay, respectively) of type 2 diabetes patients treated with relatively high doses of insulin glargine or NPH insulin (29). Here, INS is linked to type 2 diabetes mellitus.